| Product Code: ETC6736154 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China albuterol import market continued to see high concentration, with the top exporting countries being Puerto Rico, Metropolitan France, Germany, Spain, and Italy. Despite a negative compound annual growth rate (CAGR) of -2.06% from 2020 to 2024, the market experienced a significant decline in growth rate from 2023 to 2024, dropping by -26.63%. This indicates a challenging landscape for albuterol imports in China, potentially influenced by various factors such as regulatory changes, market dynamics, or shifts in demand. Stakeholders should closely monitor these trends to make informed decisions in this competitive market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Albuterol Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Albuterol Market Revenues & Volume, 2021 & 2031F |
3.3 China Albuterol Market - Industry Life Cycle |
3.4 China Albuterol Market - Porter's Five Forces |
3.5 China Albuterol Market Revenues & Volume Share, By Diseases, 2021 & 2031F |
3.6 China Albuterol Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 China Albuterol Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 China Albuterol Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 China Albuterol Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 China Albuterol Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Albuterol Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in China |
4.2.2 Growing awareness about the benefits of albuterol inhalers |
4.2.3 Rising healthcare expenditure and improved access to healthcare services in China |
4.3 Market Restraints |
4.3.1 Stringent government regulations and approval processes for pharmaceutical products |
4.3.2 Intense competition from other bronchodilator medications in the market |
4.3.3 Potential side effects and safety concerns associated with albuterol usage |
5 China Albuterol Market Trends |
6 China Albuterol Market, By Types |
6.1 China Albuterol Market, By Diseases |
6.1.1 Overview and Analysis |
6.1.2 China Albuterol Market Revenues & Volume, By Diseases, 2021- 2031F |
6.1.3 China Albuterol Market Revenues & Volume, By Asthma, 2021- 2031F |
6.1.4 China Albuterol Market Revenues & Volume, By Chronic Obstructive Pulmonary Disease (COPD), 2021- 2031F |
6.1.5 China Albuterol Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Albuterol Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 China Albuterol Market Revenues & Volume, By Albuterol Sulfate Inhalation Solution 0.083%, 2021- 2031F |
6.2.3 China Albuterol Market Revenues & Volume, By Albuterol Sulfate Inhalation Solution 0.042%, 2021- 2031F |
6.2.4 China Albuterol Market Revenues & Volume, By Albuterol Sulfate Inhalation Solution 0.021%, 2021- 2031F |
6.2.5 China Albuterol Market Revenues & Volume, By Albuterol Sulfate Inhalation Solution 0.5%, 2021- 2031F |
6.2.6 China Albuterol Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Albuterol Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 China Albuterol Market Revenues & Volume, By Generic, 2021- 2031F |
6.3.3 China Albuterol Market Revenues & Volume, By Branded, 2021- 2031F |
6.4 China Albuterol Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 China Albuterol Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 China Albuterol Market Revenues & Volume, By Inhalations, 2021- 2031F |
6.4.4 China Albuterol Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Albuterol Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 China Albuterol Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 China Albuterol Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 China Albuterol Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.5.5 China Albuterol Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Albuterol Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 China Albuterol Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.6.3 China Albuterol Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.4 China Albuterol Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.5 China Albuterol Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.6 China Albuterol Market Revenues & Volume, By Others, 2021- 2031F |
7 China Albuterol Market Import-Export Trade Statistics |
7.1 China Albuterol Market Export to Major Countries |
7.2 China Albuterol Market Imports from Major Countries |
8 China Albuterol Market Key Performance Indicators |
8.1 Number of prescriptions for albuterol inhalers |
8.2 Patient adherence rate to albuterol treatment |
8.3 Rate of new product developments and innovations in the albuterol market |
9 China Albuterol Market - Opportunity Assessment |
9.1 China Albuterol Market Opportunity Assessment, By Diseases, 2021 & 2031F |
9.2 China Albuterol Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 China Albuterol Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 China Albuterol Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 China Albuterol Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 China Albuterol Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Albuterol Market - Competitive Landscape |
10.1 China Albuterol Market Revenue Share, By Companies, 2024 |
10.2 China Albuterol Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |